Bio-Rad Signs Second Collaboration Agreement with Caliper
News Oct 27, 2005
Bio-Rad Laboratories, Inc. and Caliper Life Sciences, Inc. have announced collaboration, under which the companies will study the feasibility of developing a microfluidics system platform.
The two companies' previous collaboration, initiated in mid-2003, resulted in the launch of a microfluidics-based electrophoresis product, Experion, in the fall of 2004.
“The success we've enjoyed with the Experion™ Automated Electrophoresis System has confirmed our belief that microfluidics is a key strategic technology,” commented Norman Schwartz, president and CEO at Bio-Rad.
“After our first positive experience collaborating with Caliper, we are looking forward to this next collaboration where we will pursue new ideas regarding LabChip microfluidics as the foundation for innovative new products.”
Kevin Hrusovsky, Caliper's president and CEO, also commented, “Bio-Rad is a model partner for our 'Caliper Driven' program, under which we enable life science companies like Bio-Rad to tap into our innovative technologies, expertise and patent portfolio.”
“Their strong reputation in life sciences and diagnostics, and their well-established global distribution very effectively leverage our technology into key markets.”
China is poised to introduce a new regulation on gene editing in humans. A draft of the country’s new civil code lists human genes and embryos in a section on personality rights to be protected. Experiments on genes in adults or embryos that endanger human health or violate ethical norms can accordingly be seen as a violation of a person’s fundamental rights.READ MORE